Genetics of congenital heart disease: the contribution of the noncoding regulatory genome

Alex V Postma1,2, Connie R Bezzina3, Vincent M Christoffels1

  • 1Department of Anatomy, Embryology & Physiology, Academic Medical Center, Amsterdam, The Netherlands.

Insights

Congenital heart disease (CHD) is a common birth defect with complex causes. Advances in genetics, including next-generation sequencing, are improving our understanding of its underlying genetic factors.

Area of Science:

  • Cardiology
  • Genetics
  • Developmental Biology

Background:

  • Congenital heart disease (CHD) is the most prevalent birth defect, impacting survival and long-term health.
  • Increased life expectancy for CHD patients is attributed to surgical advancements and improved longitudinal care.
  • The genetic basis of CHD is complex and heterogeneous, involving chromosomal abnormalities and gene mutations, yet often remains unidentified.

Purpose of the Study:

  • To review current understanding of the genetic factors contributing to CHD.
  • To highlight the impact of new technologies and insights on CHD research.
  • To focus on regulatory regions of developmental genes in the context of CHD.

Main Methods:

  • Review of existing literature on CHD etiology and genetics.
  • Discussion of novel insights, including alternative inheritance paradigms.
  • Focus on next-generation sequencing technologies for genetic analysis.

Main Results:

  • Genetic factors, though complex and often elusive, play a significant role in CHD.
  • Next-generation sequencing and new insights offer powerful tools for uncovering genetic causes.
  • Variations and mutations in regulatory regions of key developmental genes are implicated in CHD.

Conclusions:

  • Despite challenges, significant progress is being made in understanding the genetic underpinnings of CHD.
  • Future research leveraging advanced technologies will be crucial for identifying causal genetic factors.
  • A deeper understanding of genetic contributions will inform diagnosis, treatment, and prevention strategies for CHD.

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
98
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
12.2K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

4.4K
Organization of Genes02:07

Organization of Genes

Overview
74.4K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
10.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K